GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SciClone Pharmaceuticals Inc (NAS:SCLN) » Definitions » Days Inventory

SciClone Pharmaceuticals (SciClone Pharmaceuticals) Days Inventory : 301.56 (As of Jun. 2017)


View and export this data going back to 1992. Start your Free Trial

What is SciClone Pharmaceuticals Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). SciClone Pharmaceuticals's Average Total Inventories for the three months ended in Jun. 2017 was $18.7 Mil. SciClone Pharmaceuticals's Cost of Goods Sold for the three months ended in Jun. 2017 was $5.7 Mil. Hence, SciClone Pharmaceuticals's Days Inventory for the three months ended in Jun. 2017 was 301.56.

The historical rank and industry rank for SciClone Pharmaceuticals's Days Inventory or its related term are showing as below:

SCLN's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 158.355
* Ranked among companies with meaningful Days Inventory only.

SciClone Pharmaceuticals's Days Inventory increased from Jun. 2016 (187.12) to Jun. 2017 (301.56). It might indicate that SciClone Pharmaceuticals's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. SciClone Pharmaceuticals's Inventory Turnover for the three months ended in Jun. 2017 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. SciClone Pharmaceuticals's Inventory-to-Revenue for the three months ended in Jun. 2017 was 0.42.


SciClone Pharmaceuticals Days Inventory Historical Data

The historical data trend for SciClone Pharmaceuticals's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciClone Pharmaceuticals Days Inventory Chart

SciClone Pharmaceuticals Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 178.92 265.07 205.82 177.04 219.68

SciClone Pharmaceuticals Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.12 204.39 239.14 236.21 301.56

Competitive Comparison of SciClone Pharmaceuticals's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, SciClone Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciClone Pharmaceuticals's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SciClone Pharmaceuticals's Days Inventory distribution charts can be found below:

* The bar in red indicates where SciClone Pharmaceuticals's Days Inventory falls into.



SciClone Pharmaceuticals Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

SciClone Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2016 is calculated as

Days Inventory (A: Dec. 2016 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2015 ) + Total Inventories (A: Dec. 2016 )) / count ) / Cost of Goods Sold (A: Dec. 2016 )*Days in Period
=( (10.976 + 16.587) / 2 ) / 22.898*365
=13.7815 / 22.898*365
=219.68

SciClone Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2017 is calculated as:

Days Inventory (Q: Jun. 2017 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2017 ) + Total Inventories (Q: Jun. 2017 )) / count ) / Cost of Goods Sold (Q: Jun. 2017 )*Days in Period
=( (15.331 + 22.039) / 2 ) / 5.654*365 / 4
=18.685 / 5.654*365 / 4
=301.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciClone Pharmaceuticals  (NAS:SCLN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

SciClone Pharmaceuticals's Inventory Turnover for the three months ended in Jun. 2017 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

SciClone Pharmaceuticals's Inventory to Revenue for the three months ended in Jun. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


SciClone Pharmaceuticals Days Inventory Related Terms

Thank you for viewing the detailed overview of SciClone Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


SciClone Pharmaceuticals (SciClone Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.
Executives
Richard J Hawkins director 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125
Nancy T Chang director 101 WESTCOTT, SUITE 603, HOUSTON TX 77007
Raymond Anthony Low director, officer: VP, Finance & Controller 25 SHADOW TREE CT, DANVILLE CA 94506
Wilson Wai-shun Cheung officer: CFO & Senior VP, Finance SCICLONE PHARMACEUTICALS, INC., 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404
Jon S Saxe director FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076
Anthony Gregg Lapointe director PO BOX 83216, GAITHERSBURG MD 20883-3216
Robert King officer: SVP of Prod. Dev/Supply Chain 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404
Winnie Wing-kei Tso other: VP, Finance and Controller 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404
Stephanie Wong officer: VP, Finance and Controller 343 OYSTER POINT BLVD #200, SOUTH SAN FRANCISCO CA 94080
Gary Titus officer: Senior VP Finance & CFO SCICLONE PHARMACEUTICALS, INC., 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404-2125
Peter Barrett director C/O ALNYLAM PHARMACEUTICALS, INC., 300 THIRD STREET, CAMBRIDGE MA 02142
Spa Essetifin 10 percent owner VIA SUDAFRICA 20, ROME L6 00144
Paolo Cavazza 10 percent owner VIA TESSERETE, 10, LUGANO V8 V8
Farmaceutica Lda Defiante 10 percent owner RUA DOS FERREIROS,260, FUNCHAL MADEIRA S1 9000-082
Dean S Woodman director 233 MOCKINGBIRD TRAIL, PALM BEACH FL 33480